{
    "SPADE_UN_16351": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_16351",
            "Peptide Name": "cHLH-p53R",
            "Source": "Synthetic",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "GARELRRLERELRRLEGGGGGGGKLAALKFKLLWLKLAC",
            "Sequence Length": 39,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:MDA-MB-231 (CC50=15.9 ± 2.3 μM); MCF-7  (CC50=16.0 ± 0.5 μM); MM96L (CC50=5.4 ± 0.3 μM ); MDA-MB-435S (CC50=5.7 ± 0.4 μM ); K562 (CC50=8.2 ± 0.4 μM)",
            "Hemolytic Activity": "Human erythrocytes:50% Hemolysis>64 µM",
            "Cytotoxicity": "HFF-1:CC50=11.9 ± 1.0 µM; MCF-10A:CC50=8.0 ± 0.8 µM; Human PBMC:CC50=48.9 ± 5.3 µM",
            "Binding Target": "Not available",
            "Linear/Cyclic": "Cyclic",
            "N-terminal Modification": "CAA, Chloroacetic acid",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C191H328N62O48S",
            "Mass": 4293.1,
            "PI": 10.91,
            "Net Charge": 6,
            "Hydrophobicity": -0.26,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Comments": "(1) The positively charged peptide targets the negative surface of cancer cells via electrostatic attractions; (2) The peptide inserts into cell membranes and enters inside cells very efficaciously; (3) Once inside cells, the peptide induces toxicity through fusion and/or disruption of intracellular organelles; (4) The cell membrane is disrupted and the cells die.",
            "Literature": [
                {
                    "Title": "Cell Membrane Composition Drives Selectivity and Toxicity of Designed Cyclic Helix-Loop-Helix Peptides with Cell Penetrating and Tumor Suppressor Properties",
                    "Pubmed ID": "31390185",
                    "Reference": "ACS Chem Biol. 2019 Sep 20;14(9)2071-2087.",
                    "Author": "Philippe GJ, Gaspar D, Sheng C, Huang YH, Benfield AH, Condon ND, Weidmann J, Lawrence N, Löwer A, Castanho MARB, Craik DJ, Troeira Henriques S.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31390185"
                }
            ],
            "Frequent Amino Acids": "LGR",
            "Absent Amino Acids": "DHIMNOPQSTUVY",
            "Basic Residues": 10,
            "Acidic Residues": 4,
            "Hydrophobic Residues": 16,
            "Polar Residues": 15,
            "Positive Residues": 10,
            "Negative Residues": 4,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_01709",
                    "Similarity": 1.0,
                    "Sequence": "GGGG"
                },
                {
                    "SPADE_ID": "SPADE_UN_08791",
                    "Similarity": 1.0,
                    "Sequence": "GGGG"
                },
                {
                    "SPADE_ID": "SPADE_UN_08792",
                    "Similarity": 1.0,
                    "Sequence": "GGGGG"
                }
            ]
        }
    }
}